StockNews.com began coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $5.00 target price on shares of AcelRx Pharmaceuticals in a research report […]
AcelRx Pharmaceuticals (NASDAQ:ACRX) Coverage Initiated at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
AcelRx Pharmaceuticals (NASDAQ:ACRX) Earns Sell Rating from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a research note released on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other analysts have also recently commented on ACRX. Alliance Global Partners began coverage on AcelRx Pharmaceuticals in a report on Monday, October […]
StockNews.com started coverage on shares of AcelRx Pharmaceuticals (NASDAQ:ACRX – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Several other equities analysts have also recently commented on ACRX. HC Wainwright reaffirmed a buy rating and set a $5.00 price objective on shares […]